Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Advertisement

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 30.09.20 in Vol 1, No 1 (2020): Jan-Dec

This paper is in the following e-collection/theme issue:

    Peer-Review Report

    Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”


    This is a peer review submitted for the paper “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19.”


    Round 1 Review

    General Comments

    The title of the manuscript presents the urgent topic of drug repurposing in the context of COVID-19. Clearly, research in this area is much needed, and the esteemed authors have put it well: “no time to lose.” The manuscript, however, suffers from some significant and obvious issues that can be summarized as follows:

    Specific Comments

    Major Comments
    1. The esteemed authors didn’t use the preferred template. Particularly, the abstract section, if the template is followed, should summarize the research background, objectives, methods, results, and conclusions. These sections are not clear from the current abstract.
    2. The manuscript is missing significant sections such as the Methods section, which is the most exciting part of any paper. It is not clear how the esteemed authors have summarized the literature (methods, experiments, tools, development environment, etc). The only methods that were mentioned was in reference number 67, but the paper has entirely missed this very significant section (among many others).
    3. The manuscript is also missing significant content that fails to demonstrate how the analysis was conducted and how the results are presented. The manuscript does not have a single figure and has only one table.
    4. The esteemed authors have immediately presented their classes (which I believe to be the Conclusion section) after the Background section. Since it does not follow the JMIR template, this manuscript does not make it possible for the information in this paper to be accessible to the reader.
    5. The esteemed authors have presented a report or an early stage whitepaper that can potentially be turned into a research paper. However, in the current stage, I don’t believe it qualifies as a publishable manuscript (not without adding a section on methods, experiments, etc, and following the recommended template). I highly recommend to the esteemed authors to search the JMIR archives for keywords such as literature, COVID, and drug repurposing and find some publications that they can potentially use as a guide to present their work.

    Conflicts of Interest

    None declared.

    Edited by G Eysenbach; This is a non–peer-reviewed article. submitted 20.09.20; accepted 22.09.20; published 30.09.20

    ©Ahmed Abdeen Hamed. Originally published in JMIRx Med (https://med.jmirx.org), 30.09.2020.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the JMIRx Med, is properly cited. The complete bibliographic information, a link to the original publication on https://med.jmirx.org/, as well as this copyright and license information must be included.